Seeking Alpha
 

ShangPharma Corporation (SHP)

- NYSE
SHP is defunct.
  • Nov. 20, 2012, 6:18 AM
    ShangPharma (SHP): Q3 EPS of $0.15 misses by $0.05. Revenue of $31.9M (+10.6% Y/Y) misses by $2.1M. (PR)
    | Comment!
  • Aug. 20, 2012, 12:23 PM
    ShangPharma (SHP -2.4%) slips after missing on its Q2 results earlier today. The company also reconfirms its guidance for net revenues for FY12. Net revenues are expected to be approximately $131.7 to $136.2 million, which represents growth of approximately 18% to 22% compared with FY11. William Blair cuts the shares to Market Perform on the report.
    | Comment!
  • Aug. 20, 2012, 7:44 AM
    ShangPharma (SHP): Q2 EPS of $0.11 misses by $0.09. Revenue of $31.8M (+15.7% Y/Y) misses by $1M. (PR)
    | Comment!
Visit Seeking Alpha's
Company Description
Currently, there's no company description for SHP.
Sector: Healthcare
Industry: Biotechnology
Country: China